Trending Stock News

Facebook (FB) Stock Price Rose While Meridian Management Co Has Boosted Position by $422,450; Hartford Investment Management Co Position in Natus Medical (BABY) Has Raised by $1.62 Million as Shares Declined

Meridian Management Co increased its stake in Facebook Inc (FB) by 22% based on its latest 2017Q3 regulatory filing with the SEC. Meridian Management Co bought 2,485 shares as the company’s stock rose 10.88% with the market. The institutional investor held 13,783 shares of the technology company at the end of 2017Q3, valued at $2.36M, up from 11,298 at the end of the previous reported quarter. Meridian Management Co who had been investing in Facebook Inc for a number of months, seems to be bullish on the $544.56B market cap company. The stock increased 1.10% or $2.035 during the last trading session, reaching $187.405. About 17.35 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since January 23, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

Hartford Investment Management Co increased its stake in Natus Medical Inc (BABY) by 38.26% based on its latest 2017Q3 regulatory filing with the SEC. Hartford Investment Management Co bought 43,866 shares as the company’s stock declined 11.93% while stock markets rallied. The institutional investor held 158,523 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $5.95M, up from 114,657 at the end of the previous reported quarter. Hartford Investment Management Co who had been investing in Natus Medical Inc for a number of months, seems to be bullish on the $880.24 million market cap company. The stock increased 0.26% or $0.075 during the last trading session, reaching $28.725. About 110,705 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since January 23, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

Investors sentiment decreased to 0.76 in Q3 2017. Its down 0.41, from 1.17 in 2017Q2. It turned negative, as 32 investors sold BABY shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported. Pax Ww Management Lc invested 1.62% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY). Farmers Merchants Investments owns 187 shares. 6,501 were accumulated by Aqr Cap Management Ltd Liability Corporation. Stoneridge Invest Limited Liability Company accumulated 9,904 shares. First Interstate Retail Bank holds 0% or 374 shares in its portfolio. Rainier Investment Limited Company stated it has 0.58% in Natus Medical Incorporated (NASDAQ:BABY). Moreover, Aperio Group Lc has 0% invested in Natus Medical Incorporated (NASDAQ:BABY). Confluence Management Lc owns 1.04M shares. Stifel reported 0.04% in Natus Medical Incorporated (NASDAQ:BABY). Hillcrest Asset Mgmt Ltd stated it has 1.62% in Natus Medical Incorporated (NASDAQ:BABY). Deutsche Retail Bank Ag reported 30,271 shares or 0% of all its holdings. Broadfin Cap Ltd, New York-based fund reported 204,400 shares. Mason Street Advisors Limited Liability Company owns 0.01% invested in Natus Medical Incorporated (NASDAQ:BABY) for 8,396 shares. National Bank & Trust Of Ny Mellon owns 0.01% invested in Natus Medical Incorporated (NASDAQ:BABY) for 520,123 shares. Rice Hall James And Assocs Limited Liability Co holds 0.73% or 440,067 shares in its portfolio.

Hartford Investment Management Co, which manages about $5.30 billion US Long portfolio, decreased its stake in Jpmorgan Chase (NYSE:JPM) by 13,308 shares to 801,413 shares, valued at $76.54 million in 2017Q3, according to the filing. It also reduced its holding in Bank Of America Corp (NYSE:BAC) by 55,204 shares in the quarter, leaving it with 2.20M shares, and cut its stake in Bristol Myers Squibb (NYSE:BMY).

Since August 14, 2017, it had 0 buys, and 2 selling transactions for $257,048 activity. 3,000 shares valued at $102,300 were sold by MOORE WILLIAM M on Monday, August 14.

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical had 10 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, June 23 by Roth Capital. The rating was initiated by Benchmark with “Buy” on Tuesday, October 4. Raymond James downgraded Natus Medical Incorporated (NASDAQ:BABY) on Thursday, February 2 to “Mkt Perform” rating. The stock of Natus Medical Incorporated (NASDAQ:BABY) earned “Buy” rating by TH Capital on Thursday, October 22. TH Capital maintained it with “Buy” rating and $51 target in Thursday, July 23 report. Roth Capital maintained Natus Medical Incorporated (NASDAQ:BABY) rating on Monday, September 11. Roth Capital has “Buy” rating and $44.0 target. The rating was maintained by TH Capital on Tuesday, January 12 with “Buy”. The rating was upgraded by Raymond James to “Outperform” on Tuesday, September 13. The rating was maintained by Roth Capital with “Buy” on Tuesday, April 5. William Blair downgraded Natus Medical Incorporated (NASDAQ:BABY) on Monday, January 8 to “Hold” rating.

Since August 7, 2017, it had 0 insider purchases, and 39 selling transactions for $957.86 million activity. Wehner David M. also sold $2.59 million worth of Facebook, Inc. (NASDAQ:FB) shares. On Thursday, September 7 the insider Zuckerberg Mark sold $42.50 million. FISCHER DAVID B. sold $2.75 million worth of Facebook, Inc. (NASDAQ:FB) on Thursday, August 24. Shares for $6.53M were sold by Schroepfer Michael Todd on Tuesday, October 10. 16,000 Facebook, Inc. (NASDAQ:FB) shares with value of $2.67 million were sold by Cox Christopher K. Koum Jan sold $109.70M worth of stock or 640,754 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *